DNA Aptamer against Glioma Cancer Cells

DNA Aptamer against Glioma Cancer Cells

$249.00$629.00

DNA Aptamers against Glioma Cancer Cells

SKU: APT-069 Category:

Background

A glioma is a type of primary tumor that starts in the glial cells of the brain or spinal cord. They are cancerous but some are extremely slow to develop. Gliomas comprise about 30% of all brain tumors and central nervous system tumors, and 80% of all malignant brain tumors. Glioma is an umbrella term for cancer of the glial cells that surround nerve endings in the brain.

Fusion BioLabs provides validated DNA aptamer against HepG2 hepatoma cells.

 

Product Specification

Aptamer type: DNA aptamer

Aptamer length: 73 bp

Affinity KD: 69-97 nM by Cell-SELEX

Storage: keep at -20°C. DNA aptamers are guaranteed stable for 12 months when properly stored.

Weight 0.5 lbs
Dimensions 1 × 1 × 1 in
Size

10 nmol, 30 nmol

DOCUMENTATION

Data Sheet

Aptamer Development Services

Nucleic Acid AptamersFind Better Aptamers using Structured Aptamer LibrariesLearn More
Magnetic beads-based SELEXFind DNA/RNA Aptamers against Targets Immobilized on Magnetic BeadsLearn More
Capture-SELEXFind DNA/RNA Aptamers Using Immobilized Aptamer LibraryLearn More
Cell-SELEXIdentify either Cell-Surfaced or Cell-Internalized DNA/RNA Aptamers Learn More
Peptide AptamersIdentify Peptide Aptamers Using Beads-Based Phage Panning PlatformLearn More
Aptamer-based Biomarker DiscoveryDiscover Biomarkers Using Aptamer-Facilitated PlatformsLearn More